Management of fetal tumors.

Détails

ID Serval
serval:BIB_CF0E38DA3793
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Titre
Management of fetal tumors.
Périodique
Best practice & research. Clinical obstetrics & gynaecology
Auteur(s)
Masmejan S., Baud D., Ryan G., Van Mieghem T.
ISSN
1532-1932 (Electronic)
ISSN-L
1521-6934
Statut éditorial
Publié
Date de publication
07/2019
Peer-reviewed
Oui
Volume
58
Pages
107-120
Langue
anglais
Notes
Publication types: Journal Article ; Review
Publication Status: ppublish
Résumé
In this review article, we discuss the most common fetal tumors, their prenatal management, and outcomes. Overall, the most important outcome predictors are tumor histology, size, vascularity, and location. Very large lesions, lesions causing cardiac failure, and hydrops and lesions obstructing the fetal airway have the poorest outcome, as they may cause fetal death or complications at the time of delivery. Fetal therapy has been developed to improve outcomes for the most severe cases and can consist of transplacental therapy (sirolimus for rhabdomyomas or steroids for hemangiomas and microcystic lung lesions) or surgical intervention (shunting of cystic masses, tumor ablation, occlusion of blood flow or airway exploration, and protection). Given the rarity of fetal tumors, patients should be referred to expert centers where care can be optimized and individualized to allow the best possible outcomes.
Mots-clé
Fetal therapy, Fetoscopy, Hydrops fetalis, Neoplasms, Shunt
Pubmed
Web of science
Création de la notice
31/03/2019 14:22
Dernière modification de la notice
01/10/2019 5:09
Données d'usage